Presentations 2017

“Defining and Measuring the value in cancer care”

Dr. Vasilios Barbounis, President, Greek College of Senology, Medical Oncologist, Head, 3rd Department of Medical Oncology, “Metropolitan” Hospital, Athens, Greece

Download the presentation (Zip 3789 KB)

“Cancer Policy in Greece: Are innovative treatments really accessible?”

Athanassios Vozikis, Assistant Professor, Director of the Laboratory of Health Economics and Management, Economics Dept., School of Economics, Business and International Studies, University of Piraeus

Download the presentation (Zip 3049 KB)

“Access to Cancer Therapy -Pharma Industry perspective”

Paschal Apostolides, President of the Hellenic Association of Pharmaceutical Companies (SFEE), General Manager at AbbVie Pharmaceuticals S.A.

Download the presentation (Zip 1965 KB)

“Access to Cancer Therapy -Patient perspective”

Kathy Apostolidis, President – Hellenic Cancer Federation-ELL.O.K., Vice President of ECPC-European Cancer Patient Coalition

Download the presentation (Zip 2104 KB)

“Chimeric antigen receptor (CAR) T-Cell & Gene therapies: the next generation treatment – Medical perspective: Confronting cancer from a different angle”

George Vassilopoulos, MD PhD, Professor of Hematology, University of Thessaly Medical School, Head, Division of Hematology Larisa University Hospital, Affiliate Investigator, Group Leader Cell and Gene Therapy Lab BRFAA, Athens

Download the presentation (Zip 1315 KB)

“Payer perspective: Access and affordability of new pharmaceutical solutions”

Hara Kani, Head of Medicines Administration Planning & Monitoring, Directorate of Medicines, National Organization for Health Services (EOPYY)

Download the presentation (Zip 1710 KB)

“Targeted therapies and Immunotherapies: Is monotherapy vs. combination the new dilemma?”

Amanda Psyrri, Associate Professor of Medical Oncology, National Kapodistrian University of Athens, Medical School, Chief of Oncology, Attikon University Hospital

Download the presentation (Zip 1883 KB)

“The uprising role of patient advocacy in rare cancers: research, health policy and access”

Jan Geissler, Director, European Patients’ Academy on Therapeutic Innovation (EUPATI)

Download the presentation (Zip 1390 KB)

“Joint Action for Rare Cancers: The role of ENRs and their impact in national Healthcare Organization”

Annalisa Trama, MD, Epidemiologist, National Cancer Institute, Milan, Italy

Download the presentation (Zip 1946 KB)

“The necessity of Registries”

Zenia Saridaki-Zoras, MD, PhD Medical Oncologist, Scientific Director of the Oncology Department “Asklepios”, Member of the Board of Directors of the Hellenic Society of Medical Oncology

Download the presentation (Zip 2477 KB)

“Childhood Cancers”

Apostolos Pourtsidis, M.D., PhD, President, Hellenic Society of Pediatric Hematology- Oncology (HeSPHO), Director NHS, Oncology Department, ‘P. and A. Kyriakou’ Children’s Hospital, Athens, Member of Clinical Research Council of European branch of International Society in Paediatric Oncology (SIOPE CRC), Collaborating Member of European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment (ExPO-r-Net)

Download the presentation (Zip 3999 KB)

“A success story “the case of GIST”

Ioannis Boukovinas, MD, PhD, PharmaD, Medical Oncologist, Head of Oncology Unit, “Bioclinic”, Thessaloniki, Greece, President of the Hellenic Society of Medical Oncology (HeSMO)

Download the presentation (Zip 2118 KB)

“Accurate Risk Stratification in Cancer: A prerequisite for Precision Medicine”

Kostas Stamatopoulos, MD, Director, Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki

Download the presentation (Zip 3579 KB)

“The use of biomarkers in clinical act”

Ioannis Mountzios, MSc, PhD, Consultant Medical Oncologist, 251 Airforce General Hospital, Athens, Greece

Download the presentation (Zip 4563 KB)

“The role of Pharma R&D in personalized medicine”

Christos Antonopoulos, MD, PhD, Business Unit Director Oncology, AstraZeneca

Download the presentation (Zip 2306 KB)